Earnings, Revenue Beat Estimates
Infosys earned $0.73 a share in its second quarter on revenue of $2.07 billion. Analysts had only expected $0.70 and $2.01 billion, respectively. INFY climbs 5 percent before the opening bell on my tradeMONSTER platform.
Osiris Sells Unit for Up to $100 Million
Osiris Therapeutics announced it would sell its culture-expanded mesenchymal stem cell business to Australia's Mesoblast for an initial payment of $50 million. That amount doubles if certain milestones are reached, and there will also be royalty payments in the low double digits on eventual product sales. OSIR rallies 14 percent in the pre-market..
Gap Drops on Weak Monthly Sales
Gap reported yesterday afternoon that sales at stores open at least a year fell 3 percent in September. Analysts were expecting a 1.6 percent gain, and now the shares are taking a hit! GPS drops almost 5 percent in early trading.
More From optionMONSTER
- Why traders keep piling into Hertz
- Why trader is buying ResMed puts
- Videocast: VIX is pricing in a deal
- Investment & Company Information
- Osiris Therapeutics